Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Maeve Jones-O'Connor"'
Autor:
Malek Z O Hassan, Ahmed Tawakol, Ying Wang, Raza M Alvi, Magid Awadalla, Maeve Jones-O'Connor, Rula B Bakar, Dahlia Banerji, Adam Rokicki, Lili Zhang, Connor P Mulligan, Michael T Osborne, Azmaeen Zarif, Basma Hammad, Annie W Chan, Lori J Wirth, Erica T Warner, Roger K Pitman, Katrina A Armstrong, Daniel Addison, Tomas G Neilan
Publikováno v:
PLoS ONE, Vol 18, Iss 8, p e0279235 (2023)
ImportanceThe mechanisms underlying the association between chronic stress and higher mortality among individuals with cancer remain incompletely understood.ObjectiveTo test the hypotheses that among individuals with active head and neck cancer, that
Externí odkaz:
https://doaj.org/article/124443f4e6884192b4caaaaad8edda33
Autor:
Amna Zafar, Zsofia D Drobni, Matthew Lei, Carlos A Gongora, Thiago Quinaglia, Uvette Y Lou, Ramya Mosarla, Sean P Murphy, Maeve Jones-O'Connor, Ali Mahmood, Sarah Hartmann, Hannah K Gilman, Colin D Weekes, Ryan Nipp, John R Clark, Jeffrey W Clark, Lawrence S Blaszkowsky, Erica Tavares, Tomas G Neilan
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0265767 (2022)
BackgroundCoronary vasospasm is a known side effect of 5-FU (fluorouracil) therapy. Beyond switching to non-5FU-based chemotherapy, there are no established treatments for 5-FU associated coronary vasospam. Our objective was to assess the safety and
Externí odkaz:
https://doaj.org/article/002769a21d784536b283e8e05bd4b73d
Autor:
Kaavya Paruchuri, Phoebe Finneran, Nicholas A Marston, Emma W Healy, John Andreo, Jr, Ryan Lynch, Alexander J Blood, Maeve Jones-O'Connor, Bradley Lander, Noreen Kelly, Maria T. Vivaldi, Kate Traynor, Stephen Wiviott, Pradeep Natarajan
Publikováno v:
EBioMedicine, Vol 72, Iss , Pp 103593- (2021)
Background: The interval between inpatient hospitalization for symptomatic coronary artery disease (CAD) and post-discharge office consultation is a vulnerable period for adverse events. Methods: Content was customized on a smartphone app-based platf
Externí odkaz:
https://doaj.org/article/044e9055b4e5406ba95979ef7fbbf5fd
Autor:
Cian P. McCarthy, Maeve Jones‐O’Connor, David S. Olshan, Sean Murphy, Saad Rehman, Joshua A. Cohen, Jinghan Cui, Avinainder Singh, Muthiah Vaduganathan, James L. Januzzi, Jason H. Wasfy
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background Type 2 myocardial infarction (T2MI) is common and associated with high cardiovascular event rates. However, the relationship between T2MI and heart failure (HF) is uncertain. Methods and Results We identified patients with T2MI at a large
Externí odkaz:
https://doaj.org/article/005baed908704e77bc6851ff5f8785e9
Autor:
Anju Nohria, Alexander R Lyon, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Magid Awadalla, Dahlia Banerji, Merna Armanious, Dipti Gupta, Sarju Ganatra, Paaladinesh Thavendiranathan, Gagan Sahni, Ryan Sullivan, Lili Zhang, Tomas G Neilan, Daniel A Zlotoff, Malek Z O Hassan, Amna Zafar, Raza M Alvi, Syed S Mahmood, Carol L Chen, Ana Barac, Maeve Jones-O'Connor, Sean P Murphy, Brian J Forrestal, Michael C Kirchberger, Otavio R Coelho-Filho, Muhammad A Rizvi, Anant Mandawat, Carlo G Tocchetti, Sarah Hartmann, Hannah K Gilman, Eduardo Zatarain-Nicolás, Lucie M Heinzerling, Justine V Cohen, John Groarke, Michael G Fradley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other
Externí odkaz:
https://doaj.org/article/e0d49c053cc347dfa4d4fbdd78de84e0
Autor:
Cian P. McCarthy, Sean Murphy, Maeve Jones-O'Connor, David S. Olshan, Jay R. Khambhati, Saad Rehman, John B. Cadigan, Jinghan Cui, Eric A. Meyerowitz, George Philippides, Lawrence S. Friedman, Aran Y. Kadar, Kathryn Hibbert, Pradeep Natarajan, Anthony F. Massaro, Erin A. Bohula, David A. Morrow, Ann E. Woolley, James L. Januzzi, Jr, Jason H. Wasfy
Publikováno v:
EClinicalMedicine, Vol 26, Iss , Pp 100504- (2020)
Background: Despite over 4 million cases of novel coronavirus disease 2019 (COVID-19) in the United States, limited data exist including socioeconomic background and post-discharge outcomes for patients hospitalized with this disease. Methods: In thi
Externí odkaz:
https://doaj.org/article/65ac3dd0b9554300968f33319df3e317
Autor:
Cian P. McCarthy, Sean Murphy, Saad Rehman, Maeve Jones‐O'Connor, David S. Olshan, Joshua A. Cohen, Jinghan Cui, Avinainder Singh, Muthiah Vaduganathan, James L. Januzzi, Jason H. Wasfy
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 10 (2020)
Background Home‐time, defined as the time spent alive outside of a healthcare institution, has emerged as a patient‐centered health outcome. The discharge locations and distribution of home‐time after a type 2 myocardial infarction are unknown.
Externí odkaz:
https://doaj.org/article/16cf59817542436babffc3876c03f1cd
Autor:
Justine V. Cohen, Doll Lauren Alexandra Golden, Syed S. Mahmood, Raza M. Alvi, Nathaniel D. Mercaldo, Malek Z. O. Hassan, Adam Rokicki, Connor Mulligan, Sean P. T. Murphy, Maeve Jones-O’Connor, Lucie M. Heinzerling, Rongras Damrongwatanasuk, Carol L. Chen, Michael C. Kirchberger, Sachin P. Shah, Muhammad A. Rizvi, Carlo G. Tocchetti, Valentina Mercurio, Donald P. Lawrence, John D. Groarke, Michael G. Fradley, Kerry L. Reynolds, Tomas G. Neilan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1 (2019)
BackgroundInfluenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibit
Externí odkaz:
https://doaj.org/article/23d13b13f69045c4aed81f89294aab8e
Autor:
Uvette Lou, Lawrence S. Blaszkowsky, Vineet K. Raghu, Sean P. Murphy, John W. Clark, Zsofia D. Drobni, Erica Tavares, Ramya C. Mosarla, Hannah K Gilman, Raza M. Alvi, Maeve Jones-O'Connor, Tomas G. Neilan, Colin D. Weekes, Sarah Hartmann, Amna Zafar, Matthew Lei, Jeffrey W. Clark
Publikováno v:
JACC: CardioOncology. 3:101-109
Background Coronary vasospasm is a recognized side effect of 5-fluorouracil (5-FU). There are limited and conflicting data on the incidence, risk factors, and prognostic effect of 5-FU–associated vasospasm. Objectives This study sought to assess th
Publikováno v:
Journal of the American College of Cardiology. 81:3506